PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 144 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $591,106 | +49.0% | 35,438 | +146.6% | 0.02% | +53.3% |
| Q2 2023 | $396,844 | -74.5% | 14,368 | -78.8% | 0.02% | -76.9% |
| Q1 2023 | $1,557,100 | +246.8% | 67,700 | +27.3% | 0.06% | +261.1% |
| Q3 2022 | $449,000 | +10.9% | 53,190 | +3.8% | 0.02% | +5.9% |
| Q2 2022 | $405,000 | -51.1% | 51,264 | +46.5% | 0.02% | -52.8% |
| Q1 2022 | $829,000 | -34.7% | 35,000 | -5.7% | 0.04% | -55.0% |
| Q4 2021 | $1,269,000 | – | 37,100 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
| Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
| Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
| RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
| Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
| COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
| Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
| BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
| HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |